Skip to main content
. 2022 Sep 12;16:100414. doi: 10.1016/j.mtbio.2022.100414

Table 4.

Pharmacokinetic parameters (mean ​± ​SD, n ​= ​3) after oral administration of F5, F7 and FR.

Formulation Cmax (μg/mL) Tmax (h) AUC0-12h (μg.h/mL) HVDt50%Cmax (h) RD (−) Remaining MTF in tablet (%)
F5 1.3 ​± ​1.0b 5.3 ​± ​0.6a 1.0 ​± ​1.6b 10.2 ​± ​1.7a 3.2 ​± ​0.5a 55.6 ​± ​4.9a
F7 2.2 ​± ​1.0a 4.3 ​± ​0.6a 1.7 ​± ​1.0a 9.4 ​± ​0.9a 2.9 ​± ​0.3a 17.5 ​± ​2.8b
FR 2.4 ​± ​1.9a 2.8 ​± ​0.4b 1.5 ​± ​0.9a 5.6 ​± ​0.6b 1.7 ​± ​0.2b

a,b Means in the same column with different superscript are different at the 0.05 level of significance.